{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-056314","form_type":"8-K","ticker":"COYA","cik":"0001835022","company_name":"Coya Therapeutics, Inc.","filed_at":"2023-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.951686+00:00","generated_at":"2026-06-18T18:48:39.285229+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Coya Therapeutics grants stock options to CEO, President/CMO, and CFO/COO","bullets":["CEO Howard Berman granted options to purchase 165,000 shares at $3.85 per share.","President/CMO Adrian Hepner and CFO/COO David Snyder each granted options for 115,000 shares.","Options vest in 36 equal monthly installments with full acceleration on change of control.","Options expire 10 years from grant date; exercise price equals closing price on grant date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-056314","json":"https://secwatch.observer/filing/0001193125-23-056314.json","markdown":"https://secwatch.observer/filing/0001193125-23-056314.md","text":"https://secwatch.observer/filing/0001193125-23-056314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523056314/0001193125-23-056314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523056314/d476471d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T18:48:39.285229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}